Science & Technology
SBIR Phase II:Novel, injectable, long-acting, local anesthetic for postoperative pain management
National Science Foundation
Opportunity #: 2233656
Award Ceiling
$1000K
Award Floor
$1000K
Close Date
Mar 31, 2025
Total Funding
$1000K
Expected Awards
1
Posted Date
Apr 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-2233656
Description
SBIR Phase Phase II award: "SBIR Phase II:Novel, injectable, long-acting, local anesthetic for postoperative pain management" awarded to Rebel Medicine Inc in Salt Lake City, Utah. Funded by National Science Foundation. Award amount: $999,979. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.